The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 28, 2017
Filed:
Aug. 14, 2014
Applicant:
Grünenthal Gmbh, Aachen, DE;
Inventors:
Bert Nolte, Aachen, DE;
Wolfgang Schröder, Aachen, DE;
Klaus Linz, Wachtberg, DE;
Werner Englberger, Stolberg, DE;
Hans Schick, Berlin, DE;
Heinz Graubaum, Berlin, DE;
Birgit Braun, Berlin, DE;
Sigrid Ozegowski, Berlin, DE;
József Bálint, Berlin, DE;
Helmut Sonnenschein, Berlin, DE;
Assignee:
GRÜNENTHAL, Aachen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 211/00 (2006.01); C07D 209/20 (2006.01); C07C 211/40 (2006.01); C07C 215/14 (2006.01); C07C 215/42 (2006.01); C07C 217/74 (2006.01); C07C 223/04 (2006.01); C07C 229/16 (2006.01); C07C 233/36 (2006.01); C07C 233/40 (2006.01); C07C 233/41 (2006.01); C07C 233/62 (2006.01); C07C 233/79 (2006.01); C07C 235/54 (2006.01); C07C 237/06 (2006.01); C07C 275/24 (2006.01); C07C 311/07 (2006.01); C07C 311/18 (2006.01); C07D 209/12 (2006.01); C07D 209/14 (2006.01); C07D 211/62 (2006.01); C07D 213/12 (2006.01); C07D 213/82 (2006.01); C07D 231/14 (2006.01); C07D 251/54 (2006.01); C07D 295/135 (2006.01); C07D 309/08 (2006.01); C07D 333/20 (2006.01); C07D 403/08 (2006.01); C07D 409/08 (2006.01); A61K 31/135 (2006.01); A61K 45/06 (2006.01); A61K 31/136 (2006.01); A61K 31/165 (2006.01); A61K 31/18 (2006.01); A61K 31/404 (2006.01); A61K 31/53 (2006.01); A61K 31/5377 (2006.01); C07C 211/54 (2006.01); C07C 237/24 (2006.01); C07C 311/37 (2006.01); C07D 251/48 (2006.01);
U.S. Cl.
CPC ...
C07D 209/20 (2013.01); A61K 31/135 (2013.01); A61K 31/136 (2013.01); A61K 31/165 (2013.01); A61K 31/18 (2013.01); A61K 31/404 (2013.01); A61K 31/53 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07C 211/40 (2013.01); C07C 211/54 (2013.01); C07C 215/14 (2013.01); C07C 215/42 (2013.01); C07C 217/74 (2013.01); C07C 223/04 (2013.01); C07C 229/16 (2013.01); C07C 233/36 (2013.01); C07C 233/40 (2013.01); C07C 233/41 (2013.01); C07C 233/62 (2013.01); C07C 233/79 (2013.01); C07C 235/54 (2013.01); C07C 237/06 (2013.01); C07C 237/24 (2013.01); C07C 275/24 (2013.01); C07C 311/07 (2013.01); C07C 311/18 (2013.01); C07C 311/37 (2013.01); C07D 209/12 (2013.01); C07D 209/14 (2013.01); C07D 211/62 (2013.01); C07D 213/12 (2013.01); C07D 213/82 (2013.01); C07D 231/14 (2013.01); C07D 251/48 (2013.01); C07D 251/54 (2013.01); C07D 295/135 (2013.01); C07D 309/08 (2013.01); C07D 333/20 (2013.01); C07D 403/08 (2013.01); C07D 409/08 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01); C07C 2101/16 (2013.01);
Abstract
The invention relates to compounds that have an affinity to the μ-opioid receptor and the ORL 1-receptor, methods for their production, medications containing these compounds and the use of these compounds for the treatment of pain and other conditions.